Ellis Investment Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $202K | Sell |
2,924
-22
| -0.7% | -$1.52K | 0.04% | 235 |
|
|
2025
Q1 | $205K | Sell |
2,946
-100
| -3% | -$6.94K | 0.04% | 224 |
|
|
2024
Q4 | $262K | Sell |
3,046
-264
| -8% | -$22.7K | 0.05% | 200 |
|
|
2024
Q3 | $394K | Buy |
3,310
+8
| +0.2% | +$952 | 0.08% | 162 |
|
|
2024
Q2 | $471K | Buy |
3,302
+73
| +2% | +$10.4K | 0.1% | 145 |
|
|
2024
Q1 | $415K | Sell |
3,229
-110
| -3% | -$14.1K | 0.09% | 153 |
|
|
2023
Q4 | $345K | Sell |
3,339
-262
| -7% | -$27.1K | 0.08% | 156 |
|
|
2023
Q3 | $327K | Buy |
3,601
+111
| +3% | +$10.1K | 0.08% | 156 |
|
|
2023
Q2 | $282K | Buy |
3,490
+18
| +0.5% | +$1.46K | 0.07% | 170 |
|
|
2023
Q1 | $276K | Buy |
3,472
+420
| +14% | +$33.4K | 0.07% | 169 |
|
|
2022
Q4 | $207K | Hold |
3,052
| – | – | 0.06% | 193 |
|
|
2022
Q3 | $152K | Buy |
3,052
+10
| +0.3% | +$498 | 0.04% | 226 |
|
|
2022
Q2 | $169K | Sell |
3,042
-208
| -6% | -$11.6K | 0.05% | 226 |
|
|
2022
Q1 | $180K | Hold |
3,250
| – | – | 0.04% | 233 |
|
|
2021
Q4 | $182K | Hold |
3,250
| – | – | 0.04% | 241 |
|
|
2021
Q3 | $156K | Buy |
3,250
+8
| +0.2% | +$384 | 0.04% | 247 |
|
|
2021
Q2 | $135K | Buy |
3,242
+24
| +0.7% | +$999 | 0.03% | 267 |
|
|
2021
Q1 | $108K | Hold |
3,218
| – | – | 0.03% | 279 |
|
|
2020
Q4 | $112K | Hold |
3,218
| – | – | 0.03% | 271 |
|
|
2020
Q3 | $111K | Buy |
3,218
+14
| +0.4% | +$483 | 0.04% | 251 |
|
|
2020
Q2 | $105K | Sell |
3,204
-612
| -16% | -$20.1K | 0.04% | 252 |
|
|
2020
Q1 | $114K | Buy |
3,816
+448
| +13% | +$13.4K | 0.05% | 176 |
|
|
2019
Q4 | $98K | Hold |
3,368
| – | – | 0.03% | 241 |
|
|
2019
Q3 | $85K | Buy |
3,368
+20
| +0.6% | +$505 | 0.03% | 256 |
|
|
2019
Q2 | $86K | Buy |
+3,348
| New | +$86K | 0.03% | 254 |
|